Serum selenium measurements in women with early-stage breast cancer with and without chemotherapy-induced ovarian failure Hollie A. BreedloveAnne M. SmithCharles L. Shapiro OriginalPaper 03 May 2006 Pages: 225 - 230
A Cohort Study of Antihypertensive Medication Use and Breast Cancer Among Danish Women Jon P. FryzekAslak H. PoulsenSøren Friis OriginalPaper 03 May 2006 Pages: 231 - 236
Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women George PentheroudakisGeorge FountzilasNicholas Pavlidis Epidemiology 02 December 2005 Pages: 237 - 244
Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer James J. DignamKelly WieandD. Lawrence Wickerham Epidemiology 06 December 2005 Pages: 245 - 254
Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients Xiang-Lin TanOdilia PopandaJenny Chang-Claude Epidemiology 06 December 2005 Pages: 255 - 262
Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells Stephen HiscoxLiam Morgan Robert I. Nicholson Preclinical study 07 December 2005 Pages: 263 - 274
The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study Ombretta SalvucciAmélie BouchardMark Basik Preclinical study 13 December 2005 Pages: 275 - 283
Human breast duct anatomy, the ‘sick lobe’ hypothesis and intraductal approaches to breast cancer James J. GoingTimothy J. Mohun Preclinical study 27 April 2006 Pages: 285 - 291
Patients with preoperatively ultrasonically uninvolved axillary lymph nodes: a distinct subgroup of early breast cancer patients Janez ZgajnarMarko HocevarNikola Besic Clinical trial 07 December 2005 Pages: 293 - 299
Genome-Wide Analysis for Loss of Heterozygosity in Primary and Recurrent Phyllodes Tumor and Fibroadenoma of Breast using Single Nucleotide Polymorphism Arrays Zhigang Charles WangAyodele BuraimohAndrea Lynn Richardson Preclinical Study 27 April 2006 Pages: 301 - 309
Phase II study of dose-dense sequential doxorubicin and docetaxel for patients with advanced operable and inoperable breast cancer Brenda W. CooperTomas RadivoyevitchPaula Silverman Clinical trial 13 December 2005 Pages: 311 - 318
Positive predictive value of breast fine needle aspiration cytology (FNAC) in combination with clinical and imaging findings: a series of 2334 subjects with abnormal cytology P. BulgaresiP. CariaggiN. Houssami Report 29 March 2006 Pages: 319 - 321
The “Sentinel Chain”: a new concept for prediction of axillary node status in breast cancer patients Moshe CarmonOded OlshaEliahu Golomb Clinical trial 27 April 2006 Pages: 323 - 328
Expression and Clinical Signification of Cytosolic Hyaluronan Levels in Invasive Breast Cancer María D. CorteL.O. González Francisco J. Vizoso Clinical trial 10 May 2006 Pages: 329 - 337
Styrene and breast cancer incidence in Texas: a comment on an ecological association Carol J. BurnsGeorge CruzanShan P. Tsai Letter to the editor 04 May 2006 Pages: 339 - 340
Comment to Anderson WF, Jatoi I, Devesa SS: Distinct Breast Cancer Incidence and Prognostic Patterns in the NCI’s SEER Program: Suggesting a Possible Link Between Etiology and Outcome. Breast Cancer Res Treat 90:127–137, 2005 Romano DemicheliGianni BonadonnaMilvia Zambetti Letter to the Editor 10 May 2006 Pages: 341 - 343